Exam #1 Flashcards
pathology
branch of medicine that investigates the nature of disease
clinical pathology
pathology applied to the solution of clinical problems
pathogenesis
development of unhealthy conditions
pathophysiology
study of altered body function due to disease
morphology
fundamental structure or form of cells or tissue
histology
study of cells and extracellular matrix of body tissues
etiology
cause of the disease
risk factors
conditions, events, or substances suspected of contributing to the development of the disease
epidemiology
study of the cause and distribution of disease in a population
incidence
number of new cases during a specified time
prevalence
number of existing cases in a population at a given point in time
morbidity
effect an illness has on a person’s life
mortality
rate of death (over a given time, for a given population or disease)
signs
observable phenomenon
EX: skin rash, cough, joint deformity, etc.
symptoms
subjective feelings expressed by the patient
EX: I feel pain/tired/dizzy, etc.
health
no universally accepted definition
- ability to function normally in society
- disease-free state
- WHO: state of complete physical, mental, and social well-being
disease
dynamic process disrupting physiologic function that manifests itself with a set of signs and symptoms
-has an etiology, pathogenesis, morphologic changes, clinical manifestations, diagnosis and clinical course
illness
sickness or derivation from a healthy state
-perception and response of the person
clinical course of an illness
1) acute: rapid onset and short duration
2) subacute: between acute and chronic (days to months)
3) chronic: long-standing illness or disability; may involve exacerbations
patient/client management model
examination evaluation diagnosis prognosis intervention
medical diagnosis
identification of pathology
PT diagnosis
-the label encompassing a cluster of signs/symptoms, syndromes, or categories
-the process of arriving at that label
EX: musculoskeletal, neuromuscular, etc.
differential diagnosis
determination of which one of several diseases may be producing symptoms
primary prevention
aimed towards removing or reducing disease risk factors
secondary prevention
promote early detection of disease and intervene to avoid further complications
tertiary prevention
aimed at limiting the impact of established disease
validity
how meaningful is the test
reliability
how consistent are the results
sensitivity
true positive
proportion of people with a positive test result who have the condition
specificity
true negative
proportion of people with a negative test who don’t have the condition
predicative value
degree of certainty that can be associated with a positive or negative finding obtained on a diagnostic test
-probability that a person does or does not have the condition given a particular test result
positive likelihood ratio
increase in odds for the condition to be present/proven
negative likelihood ratio
decrease in odds for the condition to be present/proven
likelihood ratio of 1
test neither proves or disproves the condition
snOUT
high Sensitivity, a Negative test rules OUT the diagnosis
- majority of true non-fallers correctly identified
- few false negatives
spIN
high Specificity, a Positive test rules IN the diagnosis
- majority of true fallers correctly identified
- few false positives
biomedical model of health
focus on disease process
biological state influences health
biopsychosocial model of health
psychological system and social factors interact with one’s biology to impact health
social-ecological model of health
considers intrapersonal factors in relationship to social and environmental factors
-emphasizes social and organizational factors impacting health
factors impacting health
sociodemographics health status geography race and ethnicity age and aging gender lifestyle factors behavioral factors
sociodemographics
populations shifts –> growing rural population
obesity: CNS-mediated endocrine dysfunction
hormonal problem that affects hypothalmic-pituitary-adrenal system
-stress –> cortisol secretion –> stimulates SNS –> hypothalamic arousal –> metabolic syndrome
obesity: problem of energy regulation
problem with the Na+/K+/ATP pump
-less ATPase pumps –> decreased energy
obesity: adipose cell theory
excessive number and size of fat cells
obesity: microbial theory
altered gut microbes alter energy intake, absorption and storage
geography
stress, nutrition, access to medical facilities and safety of the community, treatment variations
geographic pathology
infectious and parasitic diseases
environmental pathology
contaminants
cell membrane
- lipid bilayer: provides structure, relatively impermeable
- proteins: transmembrane, transportation
- carbohydrates: form cell coat
nucleus
control center-stores heredity material
components of the nucleus
- nucleolus: organelle that manufactures ribosomes
- nuclear envelope/membrane: contains pores-allows passage of material between nucleus and cytoplasm
- chromatin: DNA and proteins
DNA
protein synthesis, transmission of genetic material
RNA
copies and carries DNA instructions, site for protein synthesis, transports amino acids, production of protein
cytoplasm
surrounds nucleus
-contains water, electrolytes, suspend proteins, neutral fats, and glycogen molecules and organelles
ribosomes
small particles of nucleus proteins
free-floating or attached to endoplasmic reticulum
site of protein synthesis: attach to mRNA
endoplasmic reticulum
transport substances
- rough ER: contains ribosomes, proteins synthesis, modification of protein structure
- smooth ER: lipid synthesis, regulation of intracellular calcium (SER), metabolism and detoxification of hormones and drugs
golgi apparatus
modification of large proteins and lipids –> active form
-proteins synthesized in ER –> packaged in vesicles –> to golgi apparatus –> secreted
lysosomes
digestive
-vesicles containing enzymes that digest worn-out cell organelles, macromolecules, bacteria, or entire cells
peroxisomes
degrades peroxides, controls free radicals, breaks down large fatty acids
mitochondria
powerhouse
- generates fuel for energy for cellular activity (O2, ATP)
- regulate cell death (apoptosis), dysregulatory apoptosis –> disease
cytoskeleton
controls cell shape, transport and movement
microtubule specialization
cilia
flagella
catabolism
breaking down of nutrients and body tissues –> energy
- complex molecules into simpler ones
- used for energy production, recycling of molecular components, or excretion
anabolism
constructive process
- builds healthy body tissues from dietary calories and protein
- necessary for growth, maintenance and tissue repair
G-protein linked cell membrane metabolism
on-off switch for signal transmission
Enzyme (kinase)-linked cell membrane metabolism
mediate responses
ion-channel linked cell membrane metabolism
involved in electrical synaptic transmission
passive movement across cell membrane
without energy expenditure
chemical gradient
difference in number of particles on either side of membrane
electrical gradient
difference in charged particles or ions
simple diffusion
movement through membrane without carrier
facilitated diffusion
transport protein
ion channels and gates diffusion
open/close
osmosis diffusion
diffusion of water across membrane
endocytosis
incorporate material from outside the cell
exocytosis
enclosed vesicle first fuses with the plasma membrane
stress theories: general adaptation syndrome
1) alarm
2) resistance
3) exhaustion
stress theories: physiological responses and pathological states
stress –> problems with proteins
stress theories: personal factors
determine organ failure related to stress
reversible cell injuries
atrophy hypertrophy pseudohypertrophy hyperplasia metaplasia dysplasia
atrophy
reversible cell injury
- decrease in cell size or number of cells
- physiologic: shrinkage occurs in development; involves entire body
hypertrophy
reversible cell injury
- increased size of cell/organ due to increased workload or hormones
- physiologic: result of normal physiological conditions
- pathologic: result of disease conditions; adaptive or compensatory
pseudohypertrophy
reversible cell injury
-increase in size of organ or body part BUT not due to increase in same cell type; RATHER infiltration of other cell types
hyperplasia
reversible cell injury
- increase in number of cells resulting from an increased rate of cellular division
- physiologic: due to hormonal stimulation; increased functional demands; compensatory mechanism
- pathologic: abnormal proliferation of normal cells due to excessive hormonal stimulation or effects of growth factors
metaplasia
reversible cell injury
-reversible change in cell morphology –> one type of cell converts into another
dysplasia
reversible cell injury
-increased number of cells with altered morphology and loss of historical organization
irreversible cell injuries
cell death: apoptosis, necrosis, gangrene
pathologic calcifications: dystrophic, metastatic
apoptosis
irreversible cell injury
-controlled cell destruction; programmed cell death
necrosis
irreversible cell injury
-pathologic; unregulated; result of injury to cell integrity
gangrene
irreversible cell injury
- variant of necrosis
- dry: decreased arterial blood supply
- wet: decreased venous return and bacterial infection
- gas: infection of Clostridium bacteria dissolve cell membrane
dystrophic pathologic calcification
irreversible cell injury
-occurs in injured or dying tissue
metastatic pathologic calcification
irreversible cell injury
-occurs in normal tissue due to hypercalcemia
causes of cell injury
ischemia/hypoxia infections immune responses genetics nutritional factors physical factors mechanical factors chemical factors free radicals
hypoxia
cause of cell injury
-lack of sufficient oxygen, reducing oxygen metabolism and generation of ATP
bacterial infection
cause of cell injury
- invades tissue –> release toxins –> cell lysis and degradation of extracellular matrix
- sepsis: blood infection interferes with blood volume/flow –>shock
viral infection
cause of cell injury
- direct: RNA virus inserts itself into cell membrane receptor –> disturbs nucleus and/or cell membrane
- indirect: virally encoded protein inserts self into membrane –> forms channel in protein –> alters permeability of cell –> cell swelling and death
immune responses
cause of cell injury
- normal: provides a defense against foreign antigens
- abnormal: becomes overzealous (i.e. allergy, etc.)
genetics
cause of cell injury
- alter number or structure of chromosomes
- produce single gene mutations –> alter proteins
- cause multiple gene mutations –> multi-factor problems
contusion
bleeding into the skin or underlying tissues as consequence of a blow that squeezes or crushes soft tissue and ruptures blood vessels
abrasion
skin injury produced by shearing force
laceration
skin or soft tissue injury produced by sharp, incisional force
hematoma
collection of blood in soft tissue/enclose space
programmed change theory of cellular aging
aging is genetically programmed
activation of particular gene(s) after a number of cell divisions
error theory of cellular aging
accumulation of random events or damages to vital cell membranes
somatic mutation theory of cellular aging
mutations in DNA/deficit in repair mechanism
oxidative free radical theory of cellular aging
free radical damage
wear and tear theory of cellular aging
accumulated damage to vital parts of the cell
telomerase theory of cellular aging
in absence of telomerase, telomeres shorten –> decline in gene expression and inhibition of cell replication
rigor mortis
muscle stiffening occurs when the myosin cannot detach from the actin (due to deficient ATP) until lysosomal enzymes break down myofilaments
pharmacology
study of how chemical substances affect living tissue
pharmacotherapeutics
use of chemical agents to cure, prevent and diagnose medical disease
-goal is to deliver the appropriate amount of drug for a reasonable length of time to achieve desired beneficial effects while minimizing adverse effects
pharmacokinetics
how drugs get through the body and what happens to them in the body
-absorption –> distribution –> metabolism –> excretion
pharmacodynamics
potency and efficacy
pharmacogenomics
effect or influence of genetics on drugs
phases of human (clinical) testing
1) safety assessment
2) drug effectiveness -small patient sample
3) drug effectiveness -large patient sample
4) post-market surveillance
parts of a prescription
prescriber’s name and contact info
patient’s name and date
superscription: method of administration, treatment method
inscription: drug name, dose, quantity to dispense
signa: instructions to patient
refill instructions
prescriber’s signature
PO
by mouth
IV
intravenous
IM
intramuscular
QD
once a day (“daily”)
BID
twice a day
TID
three times a day
QID
four times a day
HS
at night
pharmacotherapeutic drug
drug’s action on a specific disease process
pharmacological drug
result of drug action on the body
“gated” ion channels
ligand and voltage-gated
quick opening and closing of channels
allows for ion transfer along concentration gradient
G-protein coupled receptors
- G-proteins made of alpha, beta, gamma subunit
- slower (more prolonged) opening of channels (seconds) than seen in ion channels and remain open longer
- production of second messengers
kinase-linked receptors
- transmembrane helical region with large extracellular space for ligand binding
- size of extracellular space related to size of endogenous ligand
- slower
DNA-coupled receptors
intracellular: in nucleus
stimulate gene transcription –> protein and enzyme synthesis
drug-receptor interaction: specificity
acting on only one type of receptor
drug-receptor interaction: selectivity
acting on one subtype of receptor
drug-receptor interaction: agonist
binds to receptor to create response
-when all receptors are occupied by agonist –> maximum response (not infinite)
drug-receptor interaction: antagonist
blocks receptor site; binds to receptor but doesn’t cause change
- competitive: antagonist can be overcome with greater concentration of agonist
- noncompetitive: antagonist blocks receptor site permanently; no effect with increased concentrations of agonist
graded dose-response curve: Emax
maximum response point
graded dose-response curve: Efficacy
strength of response
graded dose-response curve: Kd (ED50)
median effective dose
graded dose-response curve: Potency
concentration of drug needed to produce a given response
quantal dose-response curve: LD50
lethal to 1/2 of subjects
quantal dose-response curve: TD50
toxic/adverse effect in 1/2 of subjects
administration of drugs: oral
most convenient, most favored, most complex
first pass metabolism: liver metabolism
administration of drugs: sublingual and buccal
rapid absorption due to tissues and proximity to capillaries
administration of drugs: rectal
solutions, suspensions, or suppositories